Taxane vs. taxane: is the duel at an end? A commentary on a phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples